COMP <GO>
SGHT vs RCEL // PIOTROSKI F-SCORE QUALITY
Sight Sciences Inc. (NASDAQ) VS. Avita Medical Inc. (NASDAQ) • 15-METRIC TALLY: SGHT 6
— RCEL 2
▲ PIOTROSKI F-SCORE QUALITY LEADER: SGHT
LAST: $9.32 (-2.61%) • MKT CAP: $527.2M
piotroski-score
5/9
LAST: $15.65 (-6.34%) • MKT CAP: $516.8M
piotroski-score
4/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SGHT VS. RCEL)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | SGHT | RCEL | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 86.20% | 82.10% | +4.10 | SGHT | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -5.67% | -6.23% | +0.56 | SGHT | /fcf-yield <GO> |
| Operating Margin | -48.00% | -59.40% | +11.40 | SGHT | /operating-margins <GO> |
| Net Profit Margin | -49.70% | -60.00% | +10.30 | SGHT | /net-margins <GO> |
| Revenue Growth (YoY) | -3.10% | 11.50% | -14.60 | RCEL | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.16 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality ACTIVE | 5/9 | 4/9 | +1.00 | SGHT | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 62.6 | 71.6 | -9.00 | RCEL | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $527.2M | $516.8M | $10.4M | SGHT | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | SGHT REV | RCEL REV | SGHT GROSS % | RCEL GROSS % | SGHT FCF | RCEL FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $77.4M | $71.6M | 86.2% | 82.1% | -$29.9M | -$32.2M |
| FY 2024 | $79.9M | $64.3M | 85.5% | 85.8% | -$22.7M | -$58.1M |
| FY 2023 | $81.1M | $50.1M | — | — | -$47.2M | -$38.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SGHT // BETA —
RCEL // BETA —